Search

Your search keyword '"Adams, Emily R"' showing total 393 results

Search Constraints

Start Over You searched for: Author "Adams, Emily R" Remove constraint Author: "Adams, Emily R"
393 results on '"Adams, Emily R"'

Search Results

51. Saliva Alternative to Upper Respiratory Swabs for SARS-CoV-2 Diagnosis

52. Molecular surveillance reveals widespread colonisation by carbapenemase and extended spectrum beta-lactamase producing organisms in neonatal units in Kenya and Nigeria

53. Analytical evaluation of thirty-two SARS-CoV-2 lateral flow antigen tests demonstrates sensitivity remains with the SARS-CoV-2 Gamma lineage

54. Co-infections with chikungunya and dengue viruses, Guatemala, 2015

58. Streptococcus pneumoniae colonisation associates with impaired adaptive immune responses against SARS-CoV-2

59. Prevalence of neutralising antibodies against SARS-CoV-2 in acute infection and convalescence: A systematic review and meta-analysis

60. Lateral flow antigen tests can sensitively detect live cultured virus of the SARS-CoV-2 B1.1.7 lineage

61. ChloS-HRM, a novel assay to identify chloramphenicol-susceptible Escherichia coli and Klebsiella pneumoniae in Malawi

63. A prospective diagnostic evaluation of accuracy of self-taken and healthcare worker-taken swabs for rapid COVID-19 testing.

64. Accuracy of the Mologic COVID-19 rapid antigen test: a prospective multi-centre analytical and clinical evaluation

65. Detection of SARS-CoV-2 infection by saliva and nasopharyngeal sampling in frontline healthcare workers: an observational cohort study

66. Evaluation of Loopamp™ Leishmania Detection Kit and Leishmania Antigen ELISA for Post-Elimination Detection and Management of Visceral Leishmaniasis in Bangladesh

67. A novel magnetic bead-based extraction method for the isolation of antimicrobial resistance genes with a case study in river water in Malawi

68. Immunoglobulin-G Enzyme-Linked Immunosorbent Assay Predicts Neutralising Antibody Response in Convalescent SARS-CoV-2 Patients

69. Limit of detection in different matrices of nineteen commercially available rapid antigen tests for the detection of SARS-CoV-2

70. Limit of detection in different matrices of nineteen commercially available rapid antigen tests for the detection of SARS-CoV-2

71. Prospective observational study of SARS-CoV-2 infection, transmission and immunity in a cohort of households in Liverpool City Region, UK (COVID-LIV): a study protocol

72. A NOVEL AIR-DRIED MULTIPLEX HIGH RESOLUTION MELT ASSAY FOR THE DETECTION OF EXTENDED SPECTRUM BETA-LACTAMASE AND CARBAPENEMASE GENES

73. SARS-CoV-2 Transmission Risk from sports Equipment (STRIKE)

75. Investigation of SARS-CoV-2 Faecal Shedding in the Community: A Prospective Household Cohort Study (COVID-LIV) in the UK

76. IgG Seroconversion and Pathophysiology in Severe Acute Respiratory Syndrome Coronavirus 2 Infection

77. Longitudinal Profile of Antibody Response to SARS-CoV-2 in Patients with COVID-19 in a Setting from Sub–Saharan Africa: A Prospective Longitudinal Study

79. High SARS-CoV-2 seroprevalence in health care workers but relatively low numbers of deaths in urban Malawi

81. Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation

82. Self-sampling of capillary blood for serological testing of SARS-CoV-2 by COVID-19 IgG ELISA

84. Piperacillin/tazobactam resistant, cephalosporin susceptible Escherichia coli bloodstream infections driven by multiple resistance mechanisms across diverse sequence types

85. Epidemiology of dengue fever in Guatemala

86. Saliva offers a sensitive, specific and non-invasive alternative to upper respiratory swabs for SARS-CoV-2 diagnosis

87. Dynamics of IgG seroconversion and pathophysiology of COVID-19 infections

89. Rapid development of COVID-19 rapid diagnostics for low resource settings: accelerating delivery through transparency, responsiveness, and open collaboration

90. Assessing expanded community wide treatment for schistosomiasis: Baseline infection status and self-reported risk factors in three communities from the Greater Accra region, Ghana

92. Within-patient evolution to piperacillin/tazobactam resistance in a clinical isolate ofEscherichia colidue to IS26-mediated amplification ofblaTEM-1B

93. Evaluation of Novel Diagnostic Tools for Direct Detection of Leishmania donovani Markers in Clinical Samples to Sustain Visceral Leishmaniasis Elimination in Bangladesh

97. Investigation of SARS-CoV-2 faecal shedding in the community: a prospective household cohort study (COVID-LIV) in the UK.

98. Cutaneous leishmaniasis and co-morbid major depressive disorder: A systematic review with burden estimates

Catalog

Books, media, physical & digital resources